Fox Run Management, L.L.C. Cytom X Therapeutics, Inc. Transaction History

Fox Run Management, L.L.C.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 15, 2019	SELL	$12.69 - $18.61 $154,170 - $226,092	-12,149 Closed	0 $0
Q3 2018 Oct 05, 2018	BUY	$18.04 - $26.41 $219,167 - $320,855	12,149 New	12,149 $225,000
Q2 2018 Jul 17, 2018	SELL	$21.38 - $29.68 $330,235 - $458,437	-15,446 Closed	0 $0
Q1 2018 Apr 17, 2018	BUY	$21.76 - $34.22 $336,104 - $528,562	15,446 New	15,446 $439,000

50.7M

112K

8.3K

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $74.5M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Fox Run Management, L.L.C. with notifications on news.